Paying users zone. Data is covered by hidden.

  • Get to Bristol-Myers Squibb Co. for $15.99, or

  • get to whole website for at least 3 months from $49.99.

Microsoft Excel LibreOffice Calc


Long-term Debt and Solvency Analysis

Difficulty: Beginner


Ratios (Summary)

Bristol-Myers Squibb Co., debt and solvency ratios

Microsoft Excel LibreOffice Calc
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Debt to equity hidden hidden hidden hidden hidden
Debt to capital hidden hidden hidden hidden hidden
Interest coverage hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14).

Ratio Description The company
Debt-to-equity ratio A solvency ratio calculated as total debt divided by total shareholders' equity. Bristol-Myers Squibb Co.'s debt-to-equity ratio improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.
Debt-to-capital ratio A solvency ratio calculated as total debt divided by total debt plus shareholders' equity. Bristol-Myers Squibb Co.'s debt-to-capital ratio improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.

Ratio Description The company
Interest coverage ratio A solvency ratio calculated as EBIT divided by interest payments. Bristol-Myers Squibb Co.'s interest coverage ratio improved from 2015 to 2016 but then slightly deteriorated from 2016 to 2017.

Debt to Equity

Bristol-Myers Squibb Co., debt to equity calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in millions)
Short-term debt obligations hidden hidden hidden hidden hidden
Long-term debt, excluding current portion hidden hidden hidden hidden hidden
Total debt hidden hidden hidden hidden hidden
Total Bristol-Myers Squibb Company shareholders' equity hidden hidden hidden hidden hidden
Ratio
Debt to equity1 hidden hidden hidden hidden hidden
Benchmarks
Debt to Equity, Competitors
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
Debt to Equity, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Debt to Equity, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14).

2017 Calculations

1 Debt to equity = Total debt ÷ Total Bristol-Myers Squibb Company shareholders' equity
= hidden ÷ hidden = hidden

Ratio Description The company
Debt-to-equity ratio A solvency ratio calculated as total debt divided by total shareholders' equity. Bristol-Myers Squibb Co.'s debt-to-equity ratio improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.

Debt to Capital

Bristol-Myers Squibb Co., debt to capital calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in millions)
Short-term debt obligations hidden hidden hidden hidden hidden
Long-term debt, excluding current portion hidden hidden hidden hidden hidden
Total debt hidden hidden hidden hidden hidden
Total Bristol-Myers Squibb Company shareholders' equity hidden hidden hidden hidden hidden
Total capital hidden hidden hidden hidden hidden
Ratio
Debt to capital1 hidden hidden hidden hidden hidden
Benchmarks
Debt to Capital, Competitors
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
Debt to Capital, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Debt to Capital, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14).

2017 Calculations

1 Debt to capital = Total debt ÷ Total capital
= hidden ÷ hidden = hidden

Ratio Description The company
Debt-to-capital ratio A solvency ratio calculated as total debt divided by total debt plus shareholders' equity. Bristol-Myers Squibb Co.'s debt-to-capital ratio improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.

Interest Coverage

Bristol-Myers Squibb Co., interest coverage calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in millions)
Net earnings attributable to BMS hidden hidden hidden hidden hidden
Add: Net income attributable to noncontrolling interest hidden hidden hidden hidden hidden
Add: Income tax expense hidden hidden hidden hidden hidden
Add: Interest expense hidden hidden hidden hidden hidden
Earnings before interest and tax (EBIT) hidden hidden hidden hidden hidden
Ratio
Interest coverage1 hidden hidden hidden hidden hidden
Benchmarks
Interest Coverage, Competitors
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
Interest Coverage, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Interest Coverage, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14).

2017 Calculations

1 Interest coverage = EBIT ÷ Interest expense
= hidden ÷ hidden = hidden

Ratio Description The company
Interest coverage ratio A solvency ratio calculated as EBIT divided by interest payments. Bristol-Myers Squibb Co.'s interest coverage ratio improved from 2015 to 2016 but then slightly deteriorated from 2016 to 2017.